Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent

In Vivo

Volumn 4, Issue 3, 1990, Pages 153-160

  Han, J ^a   Jiao, L ^a   Lu, Y ^a   Sun, Z ^a   Gu, Q M ^a   Scanlon, K J ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

differentiation; drug synergy; Epstein Barr virus; oncogenes; pharmacokinetics; retinamides

Indexed keywords

RETINAMIDE DERIVATIVE; RETINOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CANCER PREVENTION; CHEMOTHERAPY; HAMSTER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; LEUKOPLAKIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CERVIX DYSPLASIA; CERVIX NEOPLASMS; DRUG EVALUATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HAMSTERS; HUMAN; LEUKOPLAKIA; MICE; MOUTH NEOPLASMS; NEOPLASMS, EXPERIMENTAL; ONCOGENES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0025140805     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)